Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.

Boerekamps A, De Weggheleire A, van den Berk GE, Lauw FN, Claassen MAA, Posthouwer D, Bierman WF, Hullegie SJ, Popping S, van de Vijver DACM, Dofferhoff ASM, Kootstra GJ, Leyten EM, den Hollander J, van Kasteren ME, Soetekouw R, Ammerlaan HSM, Schinkel J, Florence E, Arends JE, Rijnders BJA.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):269-277. doi: 10.1016/S2468-1253(18)30414-X. Epub 2019 Jan 17.

PMID:
30660617
2.

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.

Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ.

Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007.

PMID:
29186320
3.

The Value of 18F-FDG PET/CT in Diagnosis and During Follow-up in 273 Patients with Chronic Q Fever.

Kouijzer IJE, Kampschreur LM, Wever PC, Hoekstra C, van Kasteren MEE, de Jager-Leclercq MGL, Nabuurs-Franssen MH, Wegdam-Blans MCA, Ammerlaan HSM, Buijs J, Geus-Oei LF, Oyen WJG, Bleeker-Rovers CP.

J Nucl Med. 2018 Jan;59(1):127-133. doi: 10.2967/jnumed.117.192492. Epub 2017 May 25.

4.

Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult Care.

Weijsenfeld AM, Smit C, Cohen S, Wit FWNM, Mutschelknauss M, van der Knaap LC, van Zonneveld LM, Zomer BJ, Nauta N, Patist JC, Kuipers-Jansen MHJ, Smit EP, Blokhuis C, Pajkrt D; Dutch HIV Adolescents and Young Adults (AYA) Study Group, Weijsenfeld AM, Cohen S, Blokhuis C, van der Plas A, Scherpbier HJ, Mutschelknauss M, Nellen FJB, Prins JM, Pajkrt D, Smit C, Wit FWNM, Reiss P, van der Knaap L, Visser E, van Zonneveld LM, Vriesde ME, Bassant NY, van der Ende ME, van Rossum AMC, Driessen GJA, Fraaij PLA, Smit JV, Smit EP, Kastelijns MPW, den Hollander JG, Pogány K, Moons C, Kroon FP, Oude Geerdink E, van der Meche IB, Schouten WEM, Brinkman K, Ter Beest G, Gisolf EH, Richter C, Zomer BJ, Strik-Albers R, van der Flier M, Henriet SS, Koopmans PP, Patist JC, Nauta N, Geelen SPM, Wolfs TFW, Hoepelman IM, Mudrikova T, van der Meulen PA, de Jonge H, Scholvink EH, Bierman WFW, van den Berg JF, Bouwhuis JW, Faber S, van Vonderen M, Schippers JA, Lowe SH, Kuipers-Jansen MHJ, van Kasteren MEE, Brouwer AE, Pronk DC, Kortmann W.

Clin Infect Dis. 2016 Oct 15;63(8):1105-1112. doi: 10.1093/cid/ciw487. Epub 2016 Jul 20.

PMID:
27439528
5.

Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014.

Hullegie SJ, van den Berk GEL, Leyten EMS, Arends JE, Lauw FN, van der Meer JTM, Posthouwer D, van Eeden A, Koopmans PP, Richter C, van Kasteren MEE, Kroon FP, Bierman WFW, Groeneveld PHP, Lettinga KD, Soetekouw R, Peters EJG, Verhagen DWM, van Sighem AI, Claassen MAA, Rijnders BJA.

Clin Microbiol Infect. 2016 Feb;22(2):209.e1-209.e3. doi: 10.1016/j.cmi.2015.10.012. Epub 2015 Oct 17.

6.

Chronic Q fever diagnosis— consensus guideline versus expert opinion

Kampschreur LM, Wegdam-Blans MC, Wever PC, Renders NH, Delsing CE, Sprong T, van Kasteren ME, Bijlmer H, Notermans D, Oosterheert JJ, Stals FS, Nabuurs-Franssen MH, Bleeker-Rovers CP; Dutch Q Fever Consensus Group.

Emerg Infect Dis. 2015 Jul;21(7):1183-8.

7.

Cutaneous hyperpigmentation induced by doxycycline: a case series.

Keijmel SP, van Kasteren ME, Blokx WA, van der Meer JW, van Rossum M, Bleeker-Rovers CP.

Neth J Med. 2015 Jan;73(1):37-40.

8.

Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database.

Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, Hoepelman AI, van Kasteren ME, Buijs J, Renders NH, Nabuurs-Franssen MH, Oosterheert JJ, Wever PC.

J Clin Microbiol. 2014 May;52(5):1637-43. doi: 10.1128/JCM.03221-13. Epub 2014 Mar 5.

9.

[Neonatal outcomes of prevention of vertical HIV transmission; 15 years of experience in a non-university HIV centre].

Veen CA, van Kasteren ME, Fiedeldeij CA, Kuipers MH, van Dijken PJ, Obihara CC.

Ned Tijdschr Geneeskd. 2014;158(6):A6508. Dutch.

PMID:
24495366
10.

A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever.

Schoffelen T, Sprong T, Bleeker-Rovers CP, Wegdam-Blans MC, Ammerdorffer A, Pronk MJ, Soethoudt YE, van Kasteren ME, Herremans T, Bijlmer HA, Netea MG, van der Meer JW, Joosten LA, van Deuren M.

Clin Microbiol Infect. 2014 Jul;20(7):642-50. doi: 10.1111/1469-0691.12423. Epub 2013 Nov 18.

11.

Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment.

Santbergen B, Vriens PH, de Lange WC, Van Kasteren ME.

BMJ Case Rep. 2013 Jan 25;2013. pii: bcr2012008161. doi: 10.1136/bcr-2012-008161.

12.

Report of two in situ reconstructions with a saphenous spiral vein graft of Coxiella burnetii-infected aneurysms of the abdominal aorta.

Aerts PD, van Zitteren M, Van Kasteren ME, Buiting AG, Heyligers JM, Vriens PW.

J Vasc Surg. 2013 Jan;57(1):234-7. doi: 10.1016/j.jvs.2012.08.042. Epub 2012 Nov 20.

13.

Defining chronic Q fever: a matter of debate.

Kampschreur LM, Wever PC, Wegdam-Blans MC, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Coutinho RA, Schneeberger PM, Notermans DW, Bijlmer HA, Koopmans MP, Nabuurs-Franssen MH, Oosterheert JJ.

J Infect. 2012 Oct;65(4):362-3. doi: 10.1016/j.jinf.2012.08.002. Epub 2012 Aug 13. No abstract available.

PMID:
22898388
14.

Microbiological challenges in the diagnosis of chronic Q fever.

Kampschreur LM, Oosterheert JJ, Koop AM, Wegdam-Blans MC, Delsing CE, Bleeker-Rovers CP, De Jager-Leclercq MG, Groot CA, Sprong T, Nabuurs-Franssen MH, Renders NH, van Kasteren ME, Soethoudt Y, Blank SN, Pronk MJ, Groenwold RH, Hoepelman AI, Wever PC.

Clin Vaccine Immunol. 2012 May;19(5):787-90. doi: 10.1128/CVI.05724-11. Epub 2012 Mar 21.

15.

Chronic Q fever: review of the literature and a proposal of new diagnostic criteria.

Wegdam-Blans MC, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Notermans DW, Renders NH, Bijlmer HA, Lestrade PJ, Koopmans MP, Nabuurs-Franssen MH, Oosterheert JJ; Dutch Q fever Consensus Group.

J Infect. 2012 Mar;64(3):247-59. doi: 10.1016/j.jinf.2011.12.014. Epub 2011 Dec 23. Review.

PMID:
22226692
16.

Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results.

Sprenger HG, Langebeek N, Mulder PG, Ten Napel CH, Vriesendorp R, Hoepelman AI, Legrand JC, Koopmans PP, Van Kasteren ME, Bravenboer B, Ten Kate RW, Groeneveld PH, van der Werf TS, Gisolf EH, Richter C.

AIDS Patient Care STDS. 2010 Jun;24(6):361-6. doi: 10.1089/apc.2009.0236.

PMID:
20515418
17.

Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor.

van Kasteren ME, Manniën J, Ott A, Kullberg BJ, de Boer AS, Gyssens IC.

Clin Infect Dis. 2007 Apr 1;44(7):921-7. Epub 2007 Feb 14.

PMID:
17342642
18.

Effect of optimized antibiotic prophylaxis on the incidence of surgical site infection.

Manniën J, van Kasteren ME, Nagelkerke NJ, Gyssens IC, Kullberg BJ, Wille JC, de Boer AS.

Infect Control Hosp Epidemiol. 2006 Dec;27(12):1340-6. Epub 2006 Nov 22.

PMID:
17152032
19.

Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis.

van Kasteren ME, Mannien J, Kullberg BJ, de Boer AS, Nagelkerke NJ, Ridderhof M, Wille JC, Gyssens IC.

J Antimicrob Chemother. 2005 Dec;56(6):1094-102. Epub 2005 Oct 18.

PMID:
16234334
20.

Improving the process of antibiotic therapy in daily practice: interventions to optimize timing, dosage adjustment to renal function, and switch therapy.

Vogtländer NP, Van Kasteren ME, Natsch S, Kullberg BJ, Hekster YA, Van Der Meer JW.

Arch Intern Med. 2004 Jun 14;164(11):1206-12.

PMID:
15197046
21.

Perianal ulcer and rash. Secondary syphilis.

van Assen S, van Kasteren ME.

Neth J Med. 2003 Mar;61(3):82, 98. No abstract available.

PMID:
12765228
22.

Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals.

van Kasteren ME, Kullberg BJ, de Boer AS, Mintjes-de Groot J, Gyssens IC.

J Antimicrob Chemother. 2003 Jun;51(6):1389-96. Epub 2003 May 13.

PMID:
12746377
23.

[Optimizing antibiotics policy in the Netherlands. V. SWAB guidelines for perioperative antibiotic prophylaxis. Foundation Antibiotics Policy Team].

van Kasteren ME, Gyssens IC, Kullberg BJ, Bruining HA, Stobberingh EE, Goris RJ.

Ned Tijdschr Geneeskd. 2000 Oct 21;144(43):2049-55. Dutch. Erratum in: Ned Tijdschr Geneeskd 2001 Jan 13;145(2):112.

PMID:
11072507
24.

[Optimizing the antibiotics policy in the Netherlands. IV. SWAB- guidelines for antimicrobial therapy of adults with sepsis in hospitals. Foundation Antibiotics Policy Work Group].

van Kasteren ME, Stobberingh EE, Janknegt R, Wijnands WJ, van der Meer JW.

Ned Tijdschr Geneeskd. 1999 Mar 20;143(12):611-7. Dutch.

PMID:
10321287
25.

[Optimizing of antibiotics policy in the Netherlands. III. SWAB guidelines for antimicrobial therapy in adults hospitalized with bronchitis. Foundation Antibiotics Policy Work Group].

van Kasteren ME, Wijnands WJ, Stobberingh EE, Janknegt R, van der Meer JW.

Ned Tijdschr Geneeskd. 1998 Nov 14;142(46):2512-5. Dutch.

PMID:
10028339
26.

Guidelines for the prevention of antimicrobial resistance in hospitals.

Natsch S, van Kasteren ME, Kullberg BJ, van der Meer JW.

Clin Infect Dis. 1998 Jun;26(6):1482-3. No abstract available.

PMID:
9636897
27.
28.

[Optimizing antibiotics use policy in the Netherlands. I. The Netherlands Antibiotics Policy Foundation (SWAB)].

van Kasteren ME, Wijnands WJ, Stobberingh EE, Janknegt R, Verbrugh HA, van der Meer JW.

Ned Tijdschr Geneeskd. 1998 Apr 25;142(17):949-51. Dutch.

PMID:
9623167
29.

[Current antimicrobial drugs].

van Kasteren ME, Natsch S, van der Meer JW.

Ned Tijdschr Geneeskd. 1997 Dec 6;141(49):2392-6. Review. Dutch.

PMID:
9554159
30.

[Rational use of antibiotics by the dentist can prevent microbial resistance].

van Kasteren ME, Fennis JF, van der Meer JW.

Ned Tijdschr Tandheelkd. 1997 Aug;104(8):300-1. Dutch.

PMID:
11924414
31.

Epithelioid haemangioendothelioma of the lung: clinical and pathological pitfalls.

van Kasteren ME, van der Wurff AA, Palmen FM, Dolman A, Miseré JF.

Eur Respir J. 1995 Sep;8(9):1616-9.

32.

Long term follow up of radiosynovectomy with yttrium-90 silicate in haemophilic haemarthrosis.

van Kasteren ME, Nováková IR, Boerbooms AM, Lemmens JA.

Ann Rheum Dis. 1993 Jul;52(7):548-50.

Supplemental Content

Loading ...
Support Center